|
Thursday 21st November 2019 |
Text too small? |
Maxigesic painkiller manufacturer AFT Pharmaceuticals is starting to deliver on the growth strategy funded by its 2015 NZX listing, with sales in South East Asia rocketing ahead in the first six months of this year and in line with company expectations in the six months to Sept. 30. While growth...
Read the full story at BusinessDesk
https://businessdesk.co.nz/article/aft-pharmaceuticals-starts-to-hit-its-straps
No comments yet
KMD strengthens balance sheet with debt refinance
GXH - Green Cross Health Limited - Annual Shareholders' Meeting
VGL - Cineplexx Europe signs to Operational Excellence
STU - Steel & Tube - Director Resignation - Steve Reindler
Ryman Healthcare Limited Notice of Meeting 2026
Spark New Zealand FY26 Results Announcement Date
OCA - Oceania bond offer - interest rate set
VNT - Appointment of Managing Director and Group CEO of Ventia
ATM - a2MC declares $300 million special dividend
June 25th Morning Report